Commercialization: Page 57
-
The C-Suite: Executive Insights
Executive Insights CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the ...
By Taren Grom • Nov. 13, 2012 -
Crystal Ball: What's Ahead
Getting Down to Business: What’s Ahead in 2013 Thought leaders from all sectors of the industry identify what they believe are the most important business objectives for the life-sciences industry and their companies for 2013 and beyond. They also provide their insights on the strategies/approac...
By PharmaVoice Team • Nov. 13, 2012 -
The Year Ahead: Forging New Paths
Forging New Paths Ever-changing market dynamics will create an industry that is unlike the one we have today. 2013 promises to be as tumultuous as 2012, as the industry looks to contend with the political ping-pong ball that is healthcare. Faced with myriad internal and external pressures, life-s...
By Denise Myshko • Nov. 13, 2012 -
Talent Pool
Talent Pool executive appointments and promotions in the healthcare industry Pharmaceutical POOL Stuart Arbuckle Former Amgen VP Joins Vertex Vertex Pharmaceuticals has appointed Stuart Arbuckle as executive VP and chief commercial officer. Mr. Arbuckle most recently served as Amgen’s VP and regi...
By PharmaVoice Team • Nov. 8, 2012 -
On the Calendar
The Calendar Industry Events and Conferences, including SPECIAL DISCOUNTS Coming ATTRACTIONS Social Media, Mobile & Gaming for Pharma: How To Develop, Monitor, & Execute Digital Strategies To Engage Your Audiences, Strengthen Brand Awareness & Maximize Your Communication & Marketi...
By Taren Grom • Nov. 8, 2012 -
Tools of the Trade
Enlight’s Knode Partners with AstraZeneca Trend: Knode is working with leading pharma companies, academics, and researchers to develop Web-based solutions for accessing life-sciences experts and their knowledge. AstraZeneca is collaborating with Enlight Biosciences’ portfolio company, Knode, in t...
By Carolyn Gretton • Nov. 8, 2012 -
What's New
Trend: The adoption of digital platforms for gathering and consuming content has removed the traditional expert middlemen who controlled and interpreted information. The multiplatform content group (MCG) at Chandler Chicco Companies (CCC) uses storytelling know-how and expertise in the science of...
By Carolyn Gretton • Nov. 8, 2012 -
UpFront
Awards… Honored by Working Mother Bayer has been recognized by Working Mother magazine as one of the nation’s 100 best companies for working mothers. This is the ninth time in the past 10 years the company has been recognized on the annual list Clinical Research Advantage Executive Honorod Clinic...
By Taren Grom • Nov. 8, 2012 -
Letter from the Editor
Volume 12 • Number 10 Publisher Lisa Banket Editor Taren Grom Creative Director Marah Walsh Managing Editor Denise Myshko Senior Editor Robin Features Editor Kim Ribbink Contributing Editor Carolyn Gretton Design Associate Ariel Medel National Account Managers Trish Kane, Cathy Tracy WEBCAST?NETW...
By Taren Grom • Nov. 8, 2012 -
Segmentation and Personalization Brings Targets into Focus
With the tools that are available today, the industry can hone in on the right targets. Sophisticated technology and a more diverse field of targets are creating a new segmentation model that moves away from the practice of solely monitoring prescribing behaviors. The new environment requires str...
By Robin Robinson • Sept. 27, 2012 -
A Changing Mindset: Managing Managed Markets
The industry must revamp its managed markets strategies from the ground up to survive in the new reality of value propositions. Since the onset of healthcare reform, the role and power of payers have been growing steadily and has reached a point of painful reality for the industry. Starting today...
By PharmaVoice Team • Sept. 27, 2012 -
Industry Spotlight: The Man, the Molecule, the Market: Untangling Alzheimer's Mystery
Alzheimer’s disease is a progressive brain disorder that damages and eventually destroys brain cells, leading to loss of memory, thinking, and other brain functions. Alzheimer’s is not a part of normal aging, but results from a complex pattern of abnormal changes. It usually develops slowly and g...
By PharmaVoice Team • Sept. 27, 2012 -
Talent Pool
Pharmaceutical Pool Dr. Lawrence Bloch Infinity Names Business Chief Lawrence Bloch, M.D., has joined Infinity Pharmaceuticals as executive VP, chief financial officer, and chief business officer. Dr. Bloch is responsible for the company’s corporate, financial, and business development strategies...
By Carolyn Gretton • Sept. 27, 2012 -
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry Oncologists Rate Genentech Highest in Image Trend: Analysts correlate overall company image with key behaviors such as recommending products to colleagues, providing additional time for sales reps and medical science liaisons,...
By PharmaVoice Team • Sept. 27, 2012 -
Social Media
Social Media Innovators Move Beyond Corporate Facebook Pages Trend: More digital channels, more diversity, more ways to reach consumers GSK Leverages Olympic Sponsorship Through Digital Media This summer, GlaxoSmithKline provided the official laboratory services for the London 2012 Olympic and Pa...
By Robin Robinson • Sept. 27, 2012 -
Tools of the Trade
New electronic and web-based applications, sites, and technologies Physicians Interactive Unveils Zero-Click eCoupon Solution Trend: As more healthcare practitioners (HCPs) employ electronic prescription systems, they are looking for ways to build cost savings and adherence incentives into the wo...
By Carolyn Gretton • Sept. 27, 2012 -
What's New
DIA and HBA Collaborate on Women’s Leadership Project Trend: The associations’ career-building initiative focuses on regulatory, medical, legal, and compliance functions within the life-sciences industry. The DIA/HBA Leadership Project is a multiyear initiative launched by DIA and the Healthcare ...
By Carolyn Gretton • Sept. 27, 2012 -
UpFront
Awards… Amylin’s Diabetes Product Honored Amylin’s Bydureon has been honored by the Distribution Management Awards for Notable Achievements in Healthcare (DIANA) for the category of best new pharmaceutical product introduction. The DIANA award recognizes pharmaceutical and consumer product manufa...
By Taren Grom • Sept. 27, 2012 -
Are We Paying Attention to the Right Conversation?
Al Topin, President Conversation, beyond a doubt, is the marketing buzzword of the last couple of years. Listen to the conversation. Be part of the conversation. Make sure your brand isn’t left out of the conversation. Patients on Facebook. Caregivers on YouTube. Healthcare practitioners on Sermo...
By Al Topin • Aug. 31, 2012 -
Understanding the Information Needs of Today's Healthcare Decision-Maker
Understanding the Information Needs of Today’s Healthcare Decision-Maker Women make 80% of healthcare decisions. New research provides insights on the best ways to engage them. According to recent articles in TIME magazine and Harvard Business Review, as well as a host of studies and books, the e...
By Amy Krane • Aug. 31, 2012 -
The Musing of an Ad Guy: It's All Part of the Thrill
It’s a tough world out there. And advertising is no exception. Complex strategies, audience segmentation, targeted creative concepts, and the expression of these ideas across the digital world make our tasks very challenging. Add to that the time and financial pressures that impact us all and you...
By John Nosta • Aug. 31, 2012 -
Thrilling Clients?
In today’s pharma world of patent expirations, consolidations, downsizing, and shrinking budgets, we are finding that having “happy and satisfied" clients is no longer good enough. Today’s environment demands that agencies strive to build team chemistry, deepen relationships, and seek to “thrill ...
By Peter Rooney • Aug. 31, 2012 -
Direct to the ePharma Consumer in the Age of Connectivity
Direct to the ePharma Consumer — In the Age of Connectivity It is not a passing fad but a permanent shift. E-pharma consumers are here to stay, requiring pharmaceutical and medical device companies to adapt to the new digital environment. However, to understand the hesitancy of the pharma industr...
By Liz Moench • Aug. 31, 2012 -
Why Getting A Foot In the Door These Days Doesn't Involve a Foot…or even a person
Jeff Meehan, Chief Commercial Officer, MD On-line MD On-Line Inc. is a leading provider of electronic data interchange (EDI) solutions that facilitate the critical connection between doctors and payers. For more information visit mdon-line.com. { For more information about Instinctive Data, cal...
By Jeff Meehan • Aug. 31, 2012 -
PR Can Help Brand Planners Do More With Less
Jeff Hoyak, President, MCS Healthcare Public Relations MCS Healthcare Public Relations is an independent, award-winning global communications agency, which has provided its clients with creativity, service and results since 1985. { For more information, visit mcspr.com. creative PRApharma prod...
By Jeff Hoyak • Aug. 31, 2012